Fibrinogen alpha amyloidosis: insights from proteomics.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed.

1. Surface cues shape procoagulant properties of amyloidogenic microclots.Cell death & disease · 2026
   Review
2. Pathogenesis and kidney prognosis of renal amyloidosis.Cellular and molecular life sciences : CMLS · 2026
   Review
3. Feasibility of DNA-Based Diagnosis of Fibrinogen A Alpha-Chain Amyloidosis From Paraffin-Embedded Kidney Tissue.Kidney international reports · 2025
   Article
4. Proteomic analysis of plasma total exosomes and placenta-derived exosomes in patients with gestational diabetes mellitus in the first and second trimesters.BMC pregnancy and childbirth · 2024
   Article
5. Proteomic Evidence for Amyloidogenic Cross-Seeding in Fibrinaloid Microclots.International journal of molecular sciences · 2024
   Article
6. Histopathological and Immunohistochemical Characteristics of Different Types of Cardiac Amyloidosis.International journal of molecular sciences · 2024
   Observational
7. [Clinical phenotypes and genotypes of congenital fibrinogen disorder: an analysis of 16 children].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2024
   Article
8. Viruses and amyloids - a vicious liaison.Prion · 2023
   Review
9. Precise diagnosis and typing of early-stage renal immunoglobulin-derived amyloidosis by label-free quantification of parallel reaction monitoring-based targeted proteomics.BMC nephrology · 2023
   Article
10. De Novo Fibrinogen A Alpha Chain Amyloidosis in a Kidney Transplant Patient: Case Report and Literature Review.Canadian journal of kidney health and disease · 2023
    Article
11. Amyloidoses in Onco-Nephrology Practice: A Multidisciplinary Case-Based Conference Report.Canadian journal of kidney health and disease · 2023
    Article
12. Renal amyloidosis: a new time for a complete diagnosis.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2022
    Review
13. Extension of the Human Fibrinogen Database with Detailed Clinical Information-The αC-Connector Segment.International journal of molecular sciences · 2021
    Review
14. Expanding the family of extracellular chaperones: Identification of human plasma proteins with chaperone activity.Protein science : a publication of the Protein Society · 2021
    Article
15. Hepatic and Extrahepatic Sources and Manifestations in Endoplasmic Reticulum Storage Diseases.International journal of molecular sciences · 2021
    Review
16. Resolving Differential Diagnostic Problems in von Willebrand Disease, in Fibrinogen Disorders, in Prekallikrein Deficiency and in Hereditary Hemorrhagic Telangiectasia by Next-Generation Sequencing.Life (Basel, Switzerland) · 2021
    Article
17. Searching for Novel Candidate Biomarkers of RLS in Blood by Proteomic Analysis.Nature and science of sleep · 2021
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as